Crescent Capital Partners
Hrishi Goradia is an accomplished professional with a diverse background in finance, law, and research. Currently serving as Director at National Dental Care and as a Board Member at Pinnacle Rehab, Hrishi also holds the position of Private Equity Investor at Crescent Capital Partners. Previous roles include Research Assistant at the Grattan Institute and ANU College of Law, where Hrishi contributed to significant publications and advisory papers. Experience in investment banking was gained through an internship at Goldman Sachs, alongside legal practice as a Law Clerk at Herbert Smith Freehills specializing in commercial litigation. Additional analytical experience was obtained at Kearney and Oliver Wyman. Hrishi holds a Bachelor of Politics, Philosophy & Economics and a Juris Doctor from The Australian National University.
This person is not in any teams
Crescent Capital Partners
Crescent Capital Partners (Crescent) is a Sydney-based private equity firm investing in middle-market companies located in Australia and New Zealand with enterprise values between A$100 million and A$500 million. Crescent was formed in 2000 and has established itself as one of Australasia’s leading middle market private equity firms with its last three funds ranked as top quartile global funds (measured in either USD or AUD), as measured by Cambridge Associates. Crescent’s investment focus is on high-growth companies and sectors, or in industries that are undergoing structural change or that lend themselves to consolidation. Crescent’s role is to accelerate and support the senior management teams of these businesses in reaching their aspirational targets and goals. Crescent has a differentiated investment process that combines thematic and proprietary deal sourcing, with a disciplined and analytical approach to investing and a proactive approach to driving value at portfolio companies. Crescent has particular experience and skills in financial services, healthcare, branded and industrial businesses. In particular, Crescent has been the most active private equity manager in healthcare transactions in Australia measured by number of investments made in the past 10 years. Crescent has had a strong track record in delivering superior returns to investors through successful exits. Crescent is now investing our $1 billion Crescent VII (2023 vintage).